Oncology

Roche and SQZ expand cell therapy deal to more than $1.3bn

https://pharmaphorum.com/news/roche-and-sqz-expand-cell-therapy-deal-to-more-than-1-3bn/

BMS Opdivo fails in small cell lung cancer

https://pharmaphorum.com/news/bms-opdivo-fails-in-small-cell-lung-cancer/

BMS invests $12m in cancer immunotherapy tie-up with Compugen

https://pharmaphorum.com/news/bms-invests-12m-in-cancer-immunotherapy-tie-up-with-compugen/

Allogene astounds Wall Street with $324m IPO to fund cell therapy R&D

https://pharmaphorum.com/news/allogene-astounds-wall-street-with-324m-ipo-to-fund-cell-therapy-rd/

New Horizon for Treatment of Inherited Retinal Dystrophy

https://pharmaphorum.com/events/new-horizon-for-treatment-of-inherited-retinal-dystrophy/

Celltrion/Teva Rituxan biosimilar edges closer to US approval

https://pharmaphorum.com/news/celltrion-teva-rituxan-biosimilar-edges-closer-to-us-approval/

Ahead of the curve

https://pharmaphorum.com/views-analysis-oncology/ahead-curve-car-t/

Pfizer’s leukaemia drug gets NHS funding in England and Wales

https://pharmaphorum.com/news/pfizers-leukaemia-drug-gets-nhs-funding-in-england-and-wales/

Celltrion’s Rituxan biosimilar gets glowing review ahead of key meeting

https://pharmaphorum.com/news/celltrions-rituxan-biosimilar-gets-glowing-review-ahead-of-key-meeting/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search